Bristol Myers Squibb BMY
NYSE BMY
$61.51 +2.68 (+4.56%)
As of: Oct 20, 2026 · 1:16 PM EDT

Bristol Myers Squibb (BMY) Cash from Operations (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) posted Cash from Operations of $3.39 billion for Q2 2026, down 13.4% from $3.92 billion a year earlier but up 207.3% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Cash from Operations (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Operations at Bristol Myers Squibb was $12.78 billion, down 19.6% year-over-year; for FY2025, it came in at $14.16 billion, down 6.8% from FY2024.

  • Annual Cash from Operations shows a five-year compound annual growth rate of 0.1% (FY2020 to FY2025).
  • In prior years, Bristol Myers Squibb's Cash from Operations was $15.19 billion in FY2024 (+9.6%), $13.86 billion in FY2023 (+6.1%), $13.07 billion in FY2022 (-19.4%) and $16.21 billion in FY2021 (+15.3%).
  • Quarterly Cash from Operations has run from a low of $1.1 billion in Q1 2026 to a high of $6.31 billion in Q3 2025 over five years.
  • On a year-over-year basis, Cash from Operations has declined in each of the last three quarters, with an average decline of 5.0% over the last eight quarters.
  • The strongest year-over-year quarter for Cash from Operations in the past five years was Q3 2021, with growth of 132.3%; the weakest was Q4 2025, with a decline of 55.5%.
  • According to Business Quant data, Cash from Operations for the three prior quarters was $1.1 billion (Q1 2026), $1.97 billion (Q4 2025) and $6.31 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,153.61 Bn 1,122.20 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 624.26 Bn 542.79 Bn 17.26 Bn 8.62 Bn
3 AbbVie 512.23 Bn 485.34 Bn 12.70 Bn 3.44 Bn
4 Merck 365.41 Bn 319.79 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 297.24 Bn 261.23 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn 2.87 Bn
7 Amgen 234.57 Bn 189.97 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 192.81 Bn 167.01 Bn 6.22 Bn 3.57 Bn
9 Pfizer 171.68 Bn 118.33 Bn 10.94 Bn 835.00 Mn
10 Bristol Myers Squibb 125.59 Bn 76.87 Bn 9.25 Bn 3.39 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.39 Bn
Mar 31, 2026 1.10 Bn
Dec 31, 2025 1.97 Bn
Sep 30, 2025 6.31 Bn
Jun 30, 2025 3.92 Bn
Mar 31, 2025 1.95 Bn
Dec 31, 2024 4.44 Bn
Sep 30, 2024 5.59 Bn
Jun 30, 2024 2.33 Bn
Mar 31, 2024 2.83 Bn
Dec 31, 2023 4.25 Bn
Sep 30, 2023 4.75 Bn
Jun 30, 2023 1.89 Bn
Mar 31, 2023 2.97 Bn
Dec 31, 2022 3.31 Bn
Sep 30, 2022 3.69 Bn
Jun 30, 2022 2.26 Bn
Mar 31, 2022 3.81 Bn
Dec 31, 2021 4.06 Bn
Sep 30, 2021 5.27 Bn
API Access

Bristol Myers Squibb Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=BMY&period=max&api_key=YOUR_API_KEY